Kuznicki Law is investigating the proposed sale of Marrone Bio Innovations, Inc. (NasdaqCM: MBII) to Bioceres Crop Solutions Corp. (NasdaqGS: BIOX). Under the terms of the proposed transaction, shareholders of Marrone will receive only 0.088 shares of Bioceres for each share of Marrone that they own. Kuznicki Law is seeking to determine whether this consideration and the process that led to it are adequate, or whether the consideration undervalues the Company.
Marrone Bio Innovations, Inc. (NasdaqCM: MBII) Loss Submission Form
If you would like to discuss your legal rights regarding this case, you may, without obligation or cost to you, contact us toll free at (833) 835-1495 or fill out the loss submission form on this page.